Menu

Markets

Research

News

Learn
Paper trading
AI Chat
Get the app WatchlistsPortfoliosAlerts
Sign in

Kiromic BioPharma, Inc. KRBP

Full chart Compare
Set alert

Price alert · KRBP

All alert types
0.08 0.00 (+0.00%)

At closeApr 11, 2025, 4:00 PM EDT

0.081 Day range 0.3101

52-week range unavailable

Financial health

Altman Z-Score

-35.96 Distress zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

2 / 9 Weak

Nine pass/fail tests of profitability, leverage and efficiency.

Valuation

P/E -0.9×
FY 2018: -10.6×FY 2019: -11.9×FY 2020: -3.2×FY 2021: -0.7×FY 2022: -0.1×FY 2023: -0.0×FY 2024: -0.9×
FY 2018 5y median -0.7× FY 2024
P/S 0.0×
FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 0.0×
FY 2018 5y median 0.0× FY 2024
P/B -1.9×
FY 2018: 4594×FY 2019: 676×FY 2020: 163×FY 2021: 19.2×FY 2022: -15.3×FY 2023: -3.1×FY 2024: -1.9×
FY 2018 5y median -1.9× FY 2024
P/FCF -1.2×
FY 2018: -532×FY 2019: -416×FY 2020: -244×FY 2021: -23.6×FY 2022: -3.1×FY 2023: -1.3×FY 2024: -1.2×
FY 2018 5y median -3.1× FY 2024
EV/EBITDA -1.3×
FY 2018: -393×FY 2019: -369×FY 2020: -96.9×FY 2021: -19.9×FY 2022: -3.0×FY 2023: -2.5×FY 2024: -1.3×
FY 2018 5y median -3.0× FY 2024
EV/Sales 0.0×
FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 0.0×
FY 2018 5y median 0.0× FY 2024
FCF Yield -84.5%
FY 2018: -0.2%FY 2019: -0.2%FY 2020: -0.4%FY 2021: -4.2%FY 2022: -32.3%FY 2023: -74.8%FY 2024: -84.5%
FY 2018 5y median -32.3% FY 2024

Profitability

Gross Margin 0.0%
FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%
FY 2018 5y median 0.0% FY 2024
Operating Margin 0.0%
FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%
FY 2018 5y median 0.0% FY 2024
Net Margin 0.0%
FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%
FY 2018 5y median 0.0% FY 2024
ROE 213.7%
FY 2018: -1438.3%FY 2019: -189.5%FY 2020: -169.0%FY 2021: -93.9%FY 2022: 661.2%FY 2023: 233.5%FY 2024: 213.7%
FY 2018 5y median 213.7% FY 2024
ROIC -1200.1%
FY 2018: -1199.6%FY 2019: -187.2%FY 2020: -162.3%FY 2021: -92.7%FY 2022: -855.8%FY 2023: -310.5%FY 2024: -1200.1%
FY 2018 5y median -310.5% FY 2024
ROA -314.8%
FY 2018: -435.6%FY 2019: -141.4%FY 2020: -149.7%FY 2021: -83.5%FY 2022: -319.0%FY 2023: -175.0%FY 2024: -314.8%
FY 2018 5y median -175.0% FY 2024

Growth (YoY)

Revenue 0.0%
FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%
FY 2018 FY 2024
Operating Income -19.2%
FY 2018: 0.0%FY 2019: -16.4%FY 2020: -418.1%FY 2021: -34.1%FY 2022: -20.9%FY 2023: 35.9%FY 2024: -19.2%
FY 2018 FY 2024
EPS (diluted) 95.2%
FY 2018: 0.0%FY 2019: 10.5%FY 2020: -172.7%FY 2021: 14.8%FY 2022: -4.0%FY 2023: 69.5%FY 2024: 95.2%
FY 2018 FY 2024
Free Cash Flow 7.5%
FY 2018: 0.0%FY 2019: -40.5%FY 2020: -135.8%FY 2021: -192.9%FY 2022: -28.9%FY 2023: 25.1%FY 2024: 7.5%
FY 2018 FY 2024

Financial Health

Current Ratio 0.2×
FY 2018: 0.9×FY 2019: 3.0×FY 2020: 7.3×FY 2021: 7.9×FY 2022: 0.1×FY 2023: 0.2×FY 2024: 0.2×
FY 2018 5y median 0.2× FY 2024
Quick Ratio 0.2×
FY 2018: 0.9×FY 2019: 3.0×FY 2020: 7.3×FY 2021: 7.9×FY 2022: 0.1×FY 2023: 0.2×FY 2024: 0.2×
FY 2018 5y median 0.2× FY 2024
Debt / Equity -1.2×
FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 0.0×FY 2022: -1.6×FY 2023: -1.7×FY 2024: -1.2×
FY 2018 5y median -1.2× FY 2024
Net Debt / EBITDA -0.5×
FY 2018: 0.1×FY 2019: 0.5×FY 2020: 0.5×FY 2021: 1.0×FY 2022: -0.3×FY 2023: -0.8×FY 2024: -0.5×
FY 2018 5y median -0.3× FY 2024
Interest Coverage 6.4×
FY 2018: -5.0×FY 2019: -165×FY 2020: -5817×FY 2021: -2109×FY 2022: -187×FY 2023: 10.8×FY 2024: 6.4×
FY 2018 5y median -187× FY 2024

Dividends

Dividend Yield 0.0%
FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%
FY 2018 5y median 0.0% FY 2024
Payout Ratio 0.0%
FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%
FY 2018 5y median 0.0% FY 2024

Annual · latest fiscal year ends 2024-12-31